Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

CUSIP: 00439U104

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
-207,184
SEC-reported price per share
$2.97
Number of holders
20
Value change
-$607,725
Number of buys
6
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
18,244,606

Security key

00439U104

Report period

Q2 2025

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
31 Mar 2025
13F 3/4/5 Highest disclosed value: $3,015,024 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AIGH Capital Management LLC has the largest disclosed position value at $3.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value Top 5
ADAR1 Capital Management, LLC $783.2K
AIGH Capital Management LLC $3.02M
Nantahala Capital Management, LLC $2.69M
BANK OF AMERICA CORP /DE/ $1.13M
Stonepine Capital Management, LLC $665.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAR1 Capital Management, LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$783,207
343,512 shares
— 31 Mar 2025
Rajitha Grace 2018 Irrevocable Trust
3/4/5
10%+ Owner
—
denominator unverified
—
4,689,547 shares
— 27 Aug 2021
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$3,015,024
1,322,379 shares
— 31 Mar 2025
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$2,686,303
1,178,203 shares
— 31 Mar 2025
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$1,127,911
494,698 shares
— 31 Mar 2025
Stonepine Capital Management, LLC
13F
Company
13F
—
denominator unverified
$665,683
294,550 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
3,816,908
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q4 2025 Across Filers

Q4 2025 holders
22
Q2 2025 holders
20
Holder diff
-2
Investor Q4 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q4 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .